About: Trubion

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Trubion Goto Sponge NotDistinct Permalink

An Entity of Type : yago:WikicatPharmaceuticalCompaniesOfTheUnitedStates, within Data Space : dbpedia.org associated with source document(s)
QRcode icon

http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FTrubion

Trubion was a publicly held biopharmaceutical company that was focused on creating a pipeline of protein-based therapeutic product candidates to treat autoimmune and inflammatory diseases and cancer. Trubion was acquired by Emergent BioSolutions on October 28, 2010. Trubion was established in 1999 in the State of Washington as an early stage development company, and was later reincorporated in October 2002 in the State of Delaware.

Attributes	Values
rdf:type	Thing company schema:Organization dul:Agent dul:SocialPerson agent wikidata:Q24229398 Organization Business enterprise yago:WikicatBiotechnologyCompaniesOfTheUnitedStates yago:WikicatCompaniesBasedInWashington(state) yago:WikicatCompaniesListedOnNASDAQ yago:Abstraction100002137 yago:Company108058098 yago:DrugCompany108002578 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity organisation yago:SocialGroup107950920 yago:WikicatPharmaceuticalCompaniesOfTheUnitedStates
rdfs:label	Trubion (en)
rdfs:comment	Trubion was a publicly held biopharmaceutical company that was focused on creating a pipeline of protein-based therapeutic product candidates to treat autoimmune and inflammatory diseases and cancer. Trubion was acquired by Emergent BioSolutions on October 28, 2010. Trubion was established in 1999 in the State of Washington as an early stage development company, and was later reincorporated in October 2002 in the State of Delaware. (en)
foaf:name	Trubion (en)
foaf:homepage	http://www.trubion.com
name	Trubion (en)
foaf:depiction
location	Seattle, WA
dcterms:subject	Biotechnology companies of the United States 2010 disestablishments in Washington (state) 2010 mergers and acquisitions Defunct companies based in Seattle Companies formerly listed on the Nasdaq Pharmaceutical companies established in 1999 1999 establishments in Washington (state) Defunct pharmaceutical companies of the United States Biotechnology companies disestablished in 2010 Pharmaceutical companies disestablished in 2010 Biotechnology companies established in 1999
Wikipage page ID	18649568 (xsd:integer)
Wikipage revision ID	1105561452 (xsd:integer)
Link from a Wikipage to another Wikipage	Cancer Rheumatoid arthritis In vivo Antibody-dependent cell-mediated cytotoxicity Public company Biotechnology companies of the United States Chronic lymphocytic leukemia Emergent BioSolutions MAbs State of Washington 2010 disestablishments in Washington (state) 2010 mergers and acquisitions Defunct companies based in Seattle Non-Hodgkin lymphoma Companies formerly listed on the Nasdaq Pharmaceutical companies established in 1999 State of Delaware 1999 establishments in Washington (state) Defunct pharmaceutical companies of the United States Biotechnology companies disestablished in 2010 Pharmaceutical companies disestablished in 2010 Biotechnology companies established in 1999 Biopharmaceutical Systemic lupus erythematosus Autoimmune disease CD20 Seattle, WA Wyeth Small modular immunopharmaceutical Inflammatory diseases
Link from a Wikipage to an external page	http://www.trubion.com
sameAs	Trubion Trubion Trubion Trubion
dbp:wikiPageUsesTemplate	dbt:Infobox_company dbt:Primary_sources dbt:Reflist dbt:Pharmaceutical_companies_of_the_United_States
thumbnail	wiki-commons:Special:FilePath/Trubion-logo.png?width=300
fate	acquired by Emergent BioSolutions (en)
foundation	1999 (xsd:integer)
homepage	http://www.trubion.com
industry	Biopharmaceutical
location	Seattle, WA
logo	220 (xsd:integer)
products	Protein-based therapeutics (en)
traded as	NASDAQ:TRBN (en)
type	Public company
has abstract	Trubion was a publicly held biopharmaceutical company that was focused on creating a pipeline of protein-based therapeutic product candidates to treat autoimmune and inflammatory diseases and cancer. Trubion was acquired by Emergent BioSolutions on October 28, 2010. Trubion was established in 1999 in the State of Washington as an early stage development company, and was later reincorporated in October 2002 in the State of Delaware. In December 2005, Trubion entered into a collaborative agreement with Wyeth for the development and worldwide commercialization of CD20-directed therapeutics. The agreement also included the development and worldwide commercialization of certain other product candidates directed to targets other than CD20. The research portion of Trubion's contract with Wyeth extended through December 22, 2009. (en)
prov:wasDerivedFrom	wikipedia-en:Trubion?oldid=1105561452&ns=0
page length (characters) of wiki page	5840 (xsd:nonNegativeInteger)
fate	acquired byEmergent BioSolutions(2010) (en)
founding year	1999-01-01 (xsd:gYear)
industry	Biopharmaceutical

Faceted Search & Find service v1.17_git139 as of Feb 29 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (62 GB total memory, 54 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software